1996
DOI: 10.1016/s0923-2494(97)84408-2
|View full text |Cite
|
Sign up to set email alerts
|

The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
10
0

Year Published

1999
1999
2008
2008

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 16 publications
2
10
0
Order By: Relevance
“…The IL-10-secreting T cell frequency was lower in MS patients than controls (50). Also, MS patients had less serum IL-10 protein (51), blood cell IL-10 mRNA (52)(53)(54), and blood cell IL-10 protein (55) than controls. Finally, the IL-10 allele with the low expresser promoter polymorphism was more common in MS patients than controls (56,57).…”
Section: Discussionmentioning
confidence: 94%
“…The IL-10-secreting T cell frequency was lower in MS patients than controls (50). Also, MS patients had less serum IL-10 protein (51), blood cell IL-10 mRNA (52)(53)(54), and blood cell IL-10 protein (55) than controls. Finally, the IL-10 allele with the low expresser promoter polymorphism was more common in MS patients than controls (56,57).…”
Section: Discussionmentioning
confidence: 94%
“…2 However, low levels of IL-10 in serum and decreased levels of IL-10 mRNA in PBMC in MS have also been reported. 28,29 One interpretation may be that the numbers of memory cells (detected after antigenic stimulation) are increased in MS, whereas in vivo overall activated cells (observed without antigenic stimulation) are decreased. Thus, the diverging results in cytokine expression studies applying different approaches indicate the importance of selection of methods in cytokine studies.…”
Section: Discussionmentioning
confidence: 99%
“…However, repeated in vitro stimulation of these T cell lines progressively shifts cytokine production toward the Th2 response (9,10). Similarly, repeated COP-I injections may lead to deviation from Th1 to Th2 response in patients with MS (11,12). Studies reported by other investigators, however, indicate that the effect of COP-I on the induction of T cell activation is not entirely selective for Th2 cells and that it consistently activates the production of Th1 and Th2 cytokines in MS (13).…”
Section: Copolymer-i (Cop-i) Has Unique Immune Regulatory Properties mentioning
confidence: 99%